Abstract
Holmium laser lithotripsy is currently the optimum standard for surgical treatment of upper urinary calculi. This study aims to evaluate the clinical efficacy and safety of Moses compared with conventional holmium laser lithotripsy for the treatment of patients with upper urinary calculi. We conducted a systematic search using multiple databases (PubMed/Medline, Scopus, Web of Science, and ClinicalTrials.gov) until June 2022. Clinical trials comparing Moses and conventional holmium laser lithotripsy were included. Analysis was performed using RevMan version 5.4.4 software. Four studies with 892 patients were included. There were no significant differences regarding stone-free rate (mean difference [MD] 1.19, 95% CI 0.54, 2.64, p = 0.66), operative time (MD − 9.31, 95% CI − 21.11, 2.48, p = 0.12), fragmentation time (MD − 1.71, 95% CI − 11.81, 8.38, p = 0.74), total energy used (MD 1.23, 95% CI − 0.44, 2.90, p = 0.15), auxiliary procedures (MD 0.38, 95% CI 0.08, 1.90, p = 0.24), and overall complications (odds ratio [OR] 0.70, 95% CI 0.30, 1.66, p = 0.42) between the groups. However, the laser working time (MD − 0.94, 95% CI − 1.20, − 0.67, p < 0.001) of Moses technology was shorter than that of conventional technology. Moses technology has similar outcomes to regular technology in terms of safety and efficacy. Given the higher operating costs of the Moses technology, further study is required to determine whether there are benefits to this new technology.
Similar content being viewed by others
References
Chen Z, Prosperi M, Bird VY (2018) Prevalence of kidney stones in the USA: the national health and nutrition evaluation survey. J Clin Urol 12:296–302
Scales CD Jr, Tasian GE, Schwaderer AL, Goldfarb DS, Star RA, Kirkali Z (2016) Urinary stone disease: advancing knowledge, patient care, and population health. Clin J Am Soc Nephrol 11:1305–1312
Noureldin YA, Kallidonis P, Liatsikos EN (2020) Lasers for stone treatment: how safe are they? Curr Opin Urol 30:130–134
Aldoukhi AH, Roberts WW, Hall TL, Ghani KR (2019) Watch your distance: the role of laser fiber working distance on fragmentation when altering pulse width or modulation. J Endourol 33:120–126
Ibrahim A, Badaan S, Elhilali MM, Andonian S (2018) Moses technology in a stone simulator. Can Urol Assoc J 12:127–130
Elhilali MM, Badaan S, Ibrahim A, Andonian S (2017) Use of the Moses technology to improve holmium laser lithotripsy outcomes: a preclinical study. J Endourol 31:598–604
Winship B, Wollin D, Carlos E, Li J, Peters C, Simmons WN, Preminger GM, Lipkin M (2018) Dusting efficiency of the Moses holmium laser: an automated in vitro assessment. J Endourol 32:1131–1135
Mullerad M, Aguinaga JRA, Aro T, Kastin A, Goldin O, Kravtsov A, Assadi A, Badaan S, Amiel GE (2017) Initial clinical experience with a modulated holmium laser pulse-Moses technology: does it enhance laser lithotripsy efficacy? Rambam Maimonides Med J 8:e0038
Ibrahim A, Elhilali MM, Fahmy N, Carrier S, Andonian S (2020) Double-blinded prospective randomized clinical trial comparing regular and Moses modes of holmium laser lithotripsy. J Endourol 34:624–628
Knoedler MA, Li S, Best SL, Hedican SP, Penniston KL, Nakada SY (2021) Clinical impact of the institution of Moses technology on efficiency during retrograde ureteroscopy for stone disease: single-center experience. J Endourol 36:65–70
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12
Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JAC, Cochrane Bias Methods Group; Cochrane Statistical Methods Group (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj 343:d5928
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan A-W, Churchill R, Deeks JJ, Hróbjartsson A, Kirkham J, Jüni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schünemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, WhitingHiggins PFJPT (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919
Luo D, Wan X, Liu J, Tong T (2018) Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 27:1785–1805
Pietropaolo A, Hughes T, Mani M, Somani B (2021) Outcomes of ureteroscopy and laser stone fragmentation (URSL) for kidney stone disease (KSD): comparative cohort study using MOSES technology 60 W laser system versus regular holmium 20 W laser. J Clin Med 10:2742
Wang M, Shao Q, Zhu X, Wang Z, Zheng A (2021) Efficiency and clinical outcomes of Moses technology with flexible ureteroscopic laser lithotripsy for treatment of renal calculus. Urol Int 105:587–593
Dorantes-Carrillo LA, Basulto-Martínez M, Suárez-Ibarrola R, Heinze A, Proietti S, Flores-Tapia JP, Esqueda-Mendoza A, Giusti G (2022) Retrograde intrarenal surgery versus miniaturized percutaneous nephrolithotomy for kidney stones >1cm: a systematic review and meta-analysis of randomized trials. Eur Urol Focus 8:259–270
Ozbek R, Senocak C, Haberal HB, Damar E, Sadioglu FE, Bozkurt OF (2021) Comparison of scoring systems for predicting stone-free status and complications after retrograde ıntrarenal surgery. World J Urol 39:2741–2746
Ulvik Ø, Harneshaug JR, Gjengstø P (2021) What do we mean by “stone free”, and how accurate are urologists in predicting stone-free status following ureteroscopy? J Endourol 35:961–966
Dunne M, Drescher M, Abbott J, Davalos J (2021) MP18-04 lumenis pulse™ Moses™ technology improves efficiency of laser lithotripsy for patients undergoing mini-PCNL. J Urol 206:e318–e318
Kandasami SV, Mamoulakis C, El-Nahas AR, Averch T, Tuncay OL, Rawandale-Patil A, Cormio L, de la Rosette JJ (2014) Impact of case volume on outcomes of ureteroscopy for ureteral stones: the clinical research office of the endourological society ureteroscopy global study. Eur Urol 66:1046–1051
Ofude M, Shima T, Yotsuyanagi S, Ikeda D (2017) Stone attenuation values measured by average hounsfield units and stone volume as predictors of total laser energy required during ureteroscopic lithotripsy using holmium:yttrium-aluminum-garnet lasers. Urology 102:48–53
Whitehurst L, Pietropaolo A, Geraghty R, Kyriakides R, Somani BK (2020) Factors affecting operative time during ureteroscopy and stone treatment and its effect on outcomes: retrospective results over 6.5 years. Ther Adv Urol 12:1756287220934403
Mandal S, Goel A, Singh MK, Kathpalia R, Nagathan DS, Sankhwar SN, Singh V, Singh BP, Sinha RJ, Dalela D (2012) Clavien classification of semirigid ureteroscopy complications: a prospective study. Urology 80:995–1001
El-Nahas AR, El-Tabey NA, Eraky I, Shoma AM, El-Hefnawy AS, El-Assmy AM, Soliman S, Youssef RF, El-Kenawy MR, Shokeir AA, El-Kappany HA (2009) Semirigid ureteroscopy for ureteral stones: a multivariate analysis of unfavorable results. J Urol 181:1158–1162
Komori M, Izaki H, Daizumoto K, Tsuda M, Kusuhara Y, Mori H, Kagawa J, Yamaguchi K, Yamamoto Y, Fukumori T, Takahashi M, Kanayama H-O, Sakaki M, Nakatsuji H, Hamao T, Miura H (2015) Complications of flexible ureteroscopic treatment for renal and ureteral calculi during the learning curve. Urol Int 95:26–32
Stern KL, Monga M (2018) The Moses holmium system - time is money. Can J Urol 25:9313–9316
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Ethics approval
Not applicable for this type of study.
Informed consent
Not applicable for this type of study.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, J., Huang, Y., Zhu, M. et al. Does Moses technology enhance the efficiency and outcomes of regular holmium laser lithotripsy? Results of a pooled analysis of comparative studies. Lasers Med Sci 38, 73 (2023). https://doi.org/10.1007/s10103-023-03730-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10103-023-03730-4